This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heartfailure , a leading cause of hospitalization and death. hospitals from emergency rooms.
21, 2024 — The incidence rate of heartfailure was 2- to 3-fold higher among American Indian populations than rates observed in studies focused on other population groups, such as African American, Hispanic or white adults, in a new study published in the Journal of the American Heart Association.
Diabetes (16.3% to 9.2%), heartfailure (2.7% Clinical and publichealth interventions are needed to effectively manage, stem, and even reverse these adverse trends. in 2020 to 61.0% to 26.8%) and obesity (43.1% to 60.6%) will increase, whereas hypercholesterolemia will decline (45.8% to 3.8%), stroke (3.9%
Diabetes mellitus (DM) is a publichealth problem that continues to grow worldwide. 2 As noted elsewhere,3 DM and AF affect a population that shares concomitant conditions such as obesity, hypertension and even heartfailure (HF). of the population.1 of the population.1 Further, DM is a major risk for AF.
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heartfailure, chronic fatigue, and other serious health issues. The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant publichealth concern.
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heartfailure, chronic fatigue, and other serious health issues. The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant publichealth concern.
Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events. Reflecting this, some treatment guidelines for these patients now take into account factors such as diabetes and smoking status that are also used in primary-prevention risk assessment. “We
Last year if funded research in the Journal Annals of Internal Medicine that said the advice to cut sugar by PublicHealth England and other bodies such as the World Health Organisation could not be trusted. Just to choose a few paragraphs. ‘ Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content